Taiwan Reaffirms No Increase in Ractopamine Inspections Despite First Detection in Australian Pork Since 2021

Despite the recent detection of ractopamine residues in a batch of pork imported from Australia, Taiwan’s Food and Drug Administration (TFDA) has clarified it will not increase random border inspections for the controversial additive. This comes as the first instance since 2021 — when Taiwan lifted its ban on ractopamine in pork imports — that such residues have been officially reported.

According to TFDA’s pork monitoring dashboard, a 22.99 metric ton shipment of pork products from Australia, imported on April 29, was found to contain 0.001 parts per million (ppm) of ractopamine — a level well below Taiwan’s legal limit of 0.01 ppm for meat and other edible parts, and 0.04 ppm for organs like liver and kidney.

At a press conference on May 5, TFDA Director-General Chiang Chih-kang (姜至剛) stated that Taiwan would not enhance random inspections unless the detected levels exceed maximum residue limits (MRLs). The names of affected products will only be made public if violations occur.

Why This Matters: The Bigger Picture

Ractopamine, a beta-agonist feed additive used to promote lean muscle growth in pigs and cattle, has long been a point of contention in global trade and food safety debates. While 26 countries, including the U.S., Canada, Australia, and Japan, permit its use under regulated limits, the European Union, China, and Russia maintain strict bans over animal welfare and human health concerns.

In 2012, the Codex Alimentarius Commission, a global food standards-setting body under the UN, adopted international MRLs for ractopamine. However, the 69-67 vote highlighted the deep divide in global consensus, with many critics arguing that the vote was driven more by political pressures than scientific clarity.

Public Concerns and Political Sensitivities in Taiwan

Taiwan’s decision to allow imports of pork containing ractopamine in 2021 drew strong domestic backlash, particularly from consumers and opposition lawmakers concerned about health risks and lack of labeling transparency. The policy, seen as a concession to U.S. trade demands, triggered nationwide protests and became a contentious issue during elections.

Now, with the first confirmed detection — even if within legal bounds — fears are reemerging. Some legislators have suggested that this may be a strategic “test case” to ease the public into wider acceptance of American pork imports containing ractopamine.

However, Chiang strongly denied such suggestions, emphasizing that the detection was coincidental, and that TFDA maintains strict testing protocols, with over 25,000 batches tested since 2021 and only one showing positive results.

Original Insights: Why No Extra Inspections Could Still Be Risky

While Chiang assures that the detected level is safe even for daily consumption, consumer advocacy groups argue that:

• Current testing relies heavily on random sampling, which may miss smaller shipments or specialized cuts.
• The lack of product-specific public disclosure (unless MRLs are breached) undermines consumer trust and informed choice.
• Even trace levels of ractopamine have ethical implications due to concerns about animal treatment and environmental runoff from farms using the additive.

Furthermore, Taiwan’s trade partners may also view the detection differently. Countries with bans on ractopamine could question Taiwan’s food safety vigilance if more cases surface, potentially impacting Taiwan’s export credibility.

FAQs